Press Releases 2013
 
Press Releases 2012
 
Press Releases 2011
 
Press Releases 2010
 
Press Releases 2009
 
Press Releases 2008
 
Press Releases 2007
 
Press Releases 2006
 
Press Releases 2005
 
Press Releases 2004
 
Press Releases 2003
 
 
10.31.05
Microbia Presents Results from Phase 1 Trial Demonstrating MD-1100 is Active and Well-Tolerated in Healthy Volunteers
Novel, investigational therapy shows promise for the potential treatment of constipation-predominant irritable bowel syndrome

10.20.05
Microbia Appoints Dr. Jeffrey M. Johnston as Vice President, Clinical Development and Chief Medical Officer

09.15.05
Microbia Initiates Phase I Clinical Testing for Next Generation Compound for the Treatment of High Cholesterol
Novel agent, MD-0727, is specifically designed to target the intestine

05.17.05
Microbia Successfully Completes Phase IA Trial of MD-1100 for IBS-C and Other GI Disorders
Phase IB Multi-Dose Study Initiated

 

Lisa Buffington
VP, Corporate Communications
617.374.5103
 
         
Copyright © 2013, Ironwood Pharmaceuticals, Inc.All Rights Reserved|Privacy Policy|Terms of Service|Site Design